What is the address of IFUCARE?

The registered office of IFUCARE is located at Groenenborgerlaan 16, 2610 Antwerpen.

Is IFUCARE still active?

Yes. According to the CBE (29 October 2026) IFUCARE is active, legal situation “Normale toestand”, started on 25 May 2000.

Is IFUCARE registered on Peppol?

Yes, IFUCARE is registered on the Peppol network with ID 0208:0471972009.

What is the enterprise number of IFUCARE?

The enterprise number of IFUCARE is BE0471972009.

When was IFUCARE founded?

IFUCARE was founded on 25 May 2000.

Who are the directors of IFUCARE?

According to the 2025 annual accounts, the directors of IFUCARE are: Quality for You BV.

Is IFUCARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 May 2000; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did IFUCARE make in 2025?

IFUCARE posted a profit after taxes of € 1,801,582 in financial year 2025.

What is the revenue of IFUCARE?

As a small company, IFUCARE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,593,205.

How much does an employee at IFUCARE earn?

The average wage cost per full-time employee at IFUCARE was € 91,300 in 2025: staff costs of € 428,996 for 4.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does IFUCARE have?

According to the 2025 annual accounts, IFUCARE has 4.7 full-time equivalents (FTE).

IFUCARE (Private Limited) - Antwerpen - BE0471972009

Q: What does IFUCARE do?

IFUCARE is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 25 May 2000, 2 establishments.

Dossier IFUCARE, printed on 29 October 2026 from databakkes.be/en/0471972009/ifucare. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 22.5 to 4.7.

Financials

Financial year 2025

IFUCARE from Antwerpen, company number BE0471972009, closed financial year 2025 with a result of € 1.8 million after tax. For that financial year IFUCARE recorded a gross margin of € 2.6 million and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 1.1 million to € 1.8 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 3.1 million

▲ 138% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.8 million

▲ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 136,285

▲ 70% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3.1 million.

People and assets in 2025

Full-time equivalents

4.7

▼ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 428,996

▼ 13% vs 2024

€ 91,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 239,567

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 62,708

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 4,131,603 Gross margin 2022: € 4,131,603 First fiscal year in the series	€ 3,560,098 Gross margin 2023: € 3,560,098 ▼ 14% vs 2022 (€ 4,131,603) Unfavourable step	€ 1,860,984 Gross margin 2024: € 1,860,984 ▼ 48% vs 2023 (€ 3,560,098) Unfavourable step	€ 2,593,205 Gross margin 2025: € 2,593,205 ▲ 39% vs 2024 (€ 1,860,984) Favourable step	▲ 39%
Profit after taxes	€ 38,892 Profit after taxes 2022: € 38,892 First fiscal year in the series	€ 457,419 Profit after taxes 2023: € 457,419 ▲ € 418,527 vs 2022 (€ 38,892) Favourable step	€ 1,104,211 Profit after taxes 2024: € 1,104,211 ▲ 141% vs 2023 (€ 457,419) Favourable step	€ 1,801,582 Profit after taxes 2025: € 1,801,582 ▲ 63% vs 2024 (€ 1,104,211) Favourable step	▲ 63%
Equity	€ 109,425 Equity 2022: € 109,425 First fiscal year in the series	€ 566,844 Equity 2023: € 566,844 ▲ € 457,419 vs 2022 (€ 109,425) Favourable step	€ 1,309,355 Equity 2024: € 1,309,355 ▲ 131% vs 2023 (€ 566,844) Favourable step	€ 3,110,937 Equity 2025: € 3,110,937 ▲ 138% vs 2024 (€ 1,309,355) Favourable step	▲ 138%
Total debts	€ 3,261,031 Total debts 2022: € 3,261,031 First fiscal year in the series	€ 4,266,384 Total debts 2023: € 4,266,384 ▲ 31% vs 2022 (€ 3,261,031) Unfavourable step	€ 2,190,207 Total debts 2024: € 2,190,207 ▼ 49% vs 2023 (€ 4,266,384) Favourable step	€ 1,282,396 Total debts 2025: € 1,282,396 ▼ 41% vs 2024 (€ 2,190,207) Favourable step	▼ 41%
Cash	€ 267,194 Cash 2022: € 267,194 First fiscal year in the series	€ 158,473 Cash 2023: € 158,473 ▼ 41% vs 2022 (€ 267,194) Unfavourable step	€ 80,259 Cash 2024: € 80,259 ▼ 49% vs 2023 (€ 158,473) Unfavourable step	€ 136,285 Cash 2025: € 136,285 ▲ 70% vs 2024 (€ 80,259) Favourable step	▲ 70%
Retained profit	€ 90,825 Retained profit 2022: € 90,825 First fiscal year in the series	€ 548,244 Retained profit 2023: € 548,244 ▲ € 457,419 vs 2022 (€ 90,825) Favourable step	€ 1,302,624 Retained profit 2024: € 1,302,624 ▲ 138% vs 2023 (€ 548,244) Favourable step	€ 3,104,206 Retained profit 2025: € 3,104,206 ▲ 138% vs 2024 (€ 1,302,624) Favourable step	▲ 138%
Dividend	€ 1,300,000 Dividend 2022: € 1,300,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,300,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 140,000 Bank debt 2022: € 140,000 First fiscal year in the series	€ 57,827 Bank debt 2023: € 57,827 ▼ 59% vs 2022 (€ 140,000) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 57,827) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 3,370,456 Balance sheet total 2022: € 3,370,456 First fiscal year in the series	€ 4,833,228 Balance sheet total 2023: € 4,833,228 ▲ 43% vs 2022 (€ 3,370,456) Unchanged	€ 3,499,562 Balance sheet total 2024: € 3,499,562 ▼ 28% vs 2023 (€ 4,833,228) Unchanged	€ 4,393,333 Balance sheet total 2025: € 4,393,333 ▲ 26% vs 2024 (€ 3,499,562) Unchanged	▲ 26%
Employees (FTE)	23.8 Employees (FTE) 2022: 23.8 First fiscal year in the series	22.5 Employees (FTE) 2023: 22.5 ▼ 1.3 vs 2022 (23.8) Unchanged	4.9 Employees (FTE) 2024: 4.9 ▼ 17.6 vs 2023 (22.5) Unchanged	4.7 Employees (FTE) 2025: 4.7 ▼ 0.2 vs 2024 (4.9) Unchanged	▼ 0.2

Key figures of IFUCARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IFUCARE?

What happened at IFUCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 1.8 million (▲ 63% vs 2024). Source: NBB ↗
2021 Quality for You BV became a director. NBB
Aug 10, 2018 New establishment in Geel. KBO
Aug 11, 2000 New establishment in Geel. KBO
May 25, 2000 Start of the company according to the CBE. KBO

In short

From € 38,892 profit in 2022 to € 1.8 million profit in 2025.

Paid € 437,142 in corporate taxes since 2022.

Best year ever: 2025, with € 1.8 million profit.

On average € 551,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

QbD Growth 100%

The stake of QbD Growth comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

IFUCARE

Behind IFUCARE is Quality for You BV. The shares are held by QbD Growth (100%).

Directors

According to the 2025 annual accounts

Quality for You BV

Director · represented by Bart Van Acker

Also active at: Qarad EC-REP, QbD Wallonia, SIMABS, HEALTHTOMARKET, Monkeys Not Donkeys, QbD Flanders, TURNSTONE COMMUNICATIONS

since 2021

Shareholders

QbD Growth

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Groenenborgerlaan 16

2610 Antwerpen

2.115.865.354

Cipalstraat 3

2440 Geel

Active since 11 August 2000

2.279.400.723

Pas 257

2440 Geel

Active since 10 August 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.

All companies at this address →

QbD RepS same network

€ 325,288 gross margin · 2025

ISPE Belgium Affiliate vzw

Quality for You same network

QbD Growth same network

€ 12 million revenue · 2025

Administratiekantoor QbD Growth

+3 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.972.009

VAT number

BE 0471.972.009

Registered office

Groenenborgerlaan 16, 2610 Antwerpen

Names & denominations

IFUCARE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 May 2000

Peppol

Active · Active since 12 Dec 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige diensten op het gebied van informatietechnologie en computer

View on CBE Public ↗ Annual accounts (NBB) ↗

IFUCARE

Warning lights

Financials

What happened to IFUCARE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions